Boothbay Fund Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Boothbay Fund Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-31,330	Closed	-$91K	–	1384
2020 Q2	$91K	Buy	31,330 +7,230	+30%	+$22.9K	0.01%	888
2020 Q1	$68K	Buy	+24,100	New	+$77.7K	0.01%	769
2016 Q3	–	Sell	-11,952	Closed	-$38K	–	880
2016 Q2	$38K	Buy	+11,952	New	+$39.9K	0.01%	495
2016 Q1	–	Sell	-47,535	Closed	-$168K	–	697
2015 Q4	$168K	Buy	47,535 +24,471	+106%	+$102K	0.07%	450
2015 Q3	$116K	Buy	23,064 +9,958	+76%	+$57.1K	0.06%	388
2015 Q2	$84K	Buy	13,106 +2,101	+19%	+$14.1K	0.03%	377
2015 Q1	$77K	Buy	+11,005	New	+$79.7K	0.05%	302

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boothbay Fund Management's PDLI Position: Q3 2020 in Review

Boothbay Fund Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 31,330 shares — an estimated $91K sold.

Boothbay Fund Management first reported a position in PDLI in Q1 2015 and held it in 7 quarters. The position peaked at $168K in Q4 2015. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

Boothbay Fund Management reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
Boothbay Fund Management sold 31,330 PDL BioPharma, Inc. shares in Q3 2020, an estimated $91K.
Boothbay Fund Management first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 7 quarters.
Boothbay Fund Management's PDL BioPharma, Inc. position peaked at $168K in Q4 2015.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.